Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

Pedro de Oliveira Toro da Silva, Cristina Bueno Terzi, MD PhD, Antonio Luis Eiras Falcão, MD PhD, Sara T Olalla Saad, PhD, Fernando Ferreira Costa, MD PhD, Paula De Melo Campos, MD

Blood (2019) 134 (Supplement_1): 4681.

https://doi.org/10.1182/blood-2019-128884

Published: 2019

Journal Articles

National Emergency Cards for Sickle Cell Disease: A Survey on Usefulness from the Patient Perspective

Aisha Aiko Bruce, MD, Lauren Bolster, MD, Catherine Corriveau-Bourque, MD, Michelle Dang, Bsc, Ghazi S. Alotaibi, Maria McGrath, RN, Mary Anne Venner, MSN, NP, Hatoon M. Ezzat, MBBS, FRCP

Blood (2019) 134 (Supplement_1): 2171.

https://doi.org/10.1182/blood-2019-124467

Published: 2019

Journal Articles

Approaching Venous Thromboembolism Disease (DVT) from Another Perspective: Better Management in a Multidisciplinary DVT Unit Improves Clinical Outcomes and Post Thrombotic Syndrome. One-Year Experience in Our Hospital

Milagros Suito, MD, Maria Cerdá, MD, Olga Benítez, MD, Alba Cabirta, MD, Francesc Bosch, MD PhD, Amparo Santamaria, MD PhD

Blood (2019) 134 (Supplement_1): 2431.

https://doi.org/10.1182/blood-2019-131327

Published: 2019

Journal Articles

High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster

Blood (2019) 134 (Supplement_1): 3720.

https://doi.org/10.1182/blood-2019-129276

Published: 2019

Journal Articles

RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1

Blood (2019) 134 (1): 59–73.

https://doi.org/10.1182/blood.2018893982

Published: 2019

Includes: Supplemental data

Journal Articles

Synergistic Pre-Clinical Activity of Targeted Inhibition of KDM1A and BET Proteins Against Human AML Blast Progenitor Cells

Warren Fiskus, BSc, PhD, Christopher Peter Mill, PhD BA, Raffaella Soldi, Roulan Han, Dyana T. Saenz, PhD, Agnieszka J Nowak, Baohua Sun, MD PhD, David N Saenz, Courtney D. DiNardo, MD MSc, Gautam Borthakur, MD, Tapan M. Kadia, MD, Wendy Jin, Thurika Ganesh, Vaishnavi Rao, Joseph David Khoury, MD, Sunil Sharma, MD, Kapil N. Bhalla, MD

Blood (2018) 132 (Supplement 1): 3930.

https://doi.org/10.1182/blood-2018-99-114198

Published: 2018

Journal Articles

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Minkyoung Yoo, Jyothi Menon, PhD, Connor Willis, PharmD, Sudhir Unni, PhD, Trang Au, PharmD, Joseph Biskupiak, PhD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Gaetano J Bonifacio, MD, Eytan M. Stein, MD, Srinivas K. Tantravahi, MBBS, Paul J. Shami, MD, Tibor Kovacsovics, MD, Diana Brixner, PhD, David Dean Stenehjem, PharmD

Blood (2018) 132 (Supplement 1): 5857.

https://doi.org/10.1182/blood-2018-99-113479

Published: 2018

Journal Articles

Re-Presentation to Medical Care Due to Adverse Effects of Intravenous Immunoglobulin Therapy in Pediatric Immune Thrombocytopenia Patients

Amanda Grimes, MD, Taylor Olmsted, MD, Susan E. Kirk, PA-C, Michele P. Lambert, MD, Jenny M. Despotovic, DO, MS

Blood (2017) 130 (Supplement 1): 3413.

https://doi.org/10.1182/blood.V130.Suppl_1.3413.3413

Published: 2017

Journal Articles

the Impact of Dedicated Emergency and Admission Units on Infection and Death Risks in Hematological Patients Presented toa Tertiary Care Center

Yishai Ofran, MD, Galit B. Yom-Tov, PhD, Inneke van Nieuwenhuyse, PhD, Bram Foubert, PhD, Raïsa Carmen

Blood (2017) 130 (Supplement 1): 533.

https://doi.org/10.1182/blood.V130.Suppl_1.533.533

Published: 2017

Journal Articles

Targeted Therapy for AML Expressing RUNX1 Mutation

Christopher Peter Mill, PhD BA, Warren Fiskus, BSc,PhD, Courtney D. DiNardo, MDMSc, Yimin Qian, PhD, Kanak Raina, PhD, Koichi Takahashi, MD, Tapan Kadia, MD, Dyana T. Saenz, PhD, Agnieszka J Nowak, Baohua Sun, MD PhD, Craig M Crews, PhD, Kapil N. Bhalla, MD

Blood (2017) 130 (Supplement 1): 2472.

https://doi.org/10.1182/blood.V130.Suppl_1.2472.2472

Published: 2017

Journal Articles

Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients

Stella Bowcock, MDMA, Catherine Atkin, MD, Gulnaz Iqbal, PhD, Tim Planche, MDPhD, Guy Pratt, MD FRCP, FRCPath, Kwee Yong, PhD, Jill Wood, MPH, Kerry Raynes, MSc, Eric Low, BSc, Helen Higgins, MSc, Janet Dunn, PhD, Mark T Drayson, MD PhD

Blood (2017) 130 (Supplement 1): 2132.

https://doi.org/10.1182/blood.V130.Suppl_1.2132.2132

Published: 2017

Journal Articles

Monitoring Voriconazole Pharmacogenomics and Plasma Concentrations in the Treatment and Prevention of Invasive Fungal Disease for Chinese Hematological Patients

XiaoWen Tang, MD, Honglan Qu, Dandan Guo, Ting Xu, Haiping Dai, Zheng Li, Jia Yin, Xiaopeng Tian, Danqing Guo, Yang Xu, MD PhD, Xiaming Zhu, Liyan Miao, Depei Wu, MD

Blood (2017) 130 (Supplement 1): 4827.

https://doi.org/10.1182/blood.V130.Suppl_1.4827.4827

Published: 2017

Journal Articles

Reperfusion Shutdown: Delayed Onset of Fibrinolysis Resistance after Resuscitation from Hemorrhagic Shock Is Associated with Increased Circulating Levels of Plasminogen Activator Inhibitor-1 and Postinjury Complications

Hunter B Moore, MD, Ernest E Moore, MD, Eduardo Gonzalez, MD, Benjamin J Huebner, MD, Forest Sheppard, MD, Anirban Banerjee, PhD, Angela Sauaia, MD PhD, Christopher C. Silliman, MD PhD

Blood (2016) 128 (22): 206.

https://doi.org/10.1182/blood.V128.22.206.206

Published: 2016

Journal Articles

Genome-Wide Abnormality Patterns of B-Lineage Acute Lymphoblastic Leukemia in Adults in Comparison with Pediatric Cases

Blood (2014) 124 (21): 3786.

https://doi.org/10.1182/blood.V124.21.3786.3786

Published: 2014

Journal Articles

The VIP (Very Immunocompromised Patient) Protocol: Improved Access To Care and Time To Antibiotics

Paul J. Shaughnessy, MD, Ann Kelley, RN, Roberta Tremper, RN, Jonathan Tinker, Carlos Bachier, MD, Joseph Holahan, MD, Roger M. Lyons, MD, Charles F. LeMaistre, MD

Blood (2013) 122 (21): 2978.

https://doi.org/10.1182/blood.V122.21.2978.2978

Published: 2013

Journal Articles

Effector memory CD4 + T cells mediate graft-versus-leukemia without inducing graft-versus-host disease

Hong Zheng, Catherine Matte-Martone, Hongmei Li, Britt E. Anderson, Srividhya Venketesan, Hung Sheng Tan, Dhanpat Jain, Jennifer McNiff, Warren D. Shlomchik

Blood (2008) 111 (4): 2476–2484.

https://doi.org/10.1182/blood-2007-08-109678

Published: 2008

Journal Articles

Urgent Reversal of Warfarin Anticoagulation with Prothrombin Complex Concentrate.

Michael W. Lankiewicz, MD, John Hays, MT (ASCP) SBB, Kenneth D. Friedman, MD, Philip M. Blatt, MD, FACP

Blood (2004) 104 (11): 2723.

https://doi.org/10.1182/blood.V104.11.2723.2723

Published: 2004

NARROW

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

National Emergency Cards for Sickle Cell Disease: A Survey on Usefulness from the Patient Perspective

Approaching Venous Thromboembolism Disease (DVT) from Another Perspective: Better Management in a Multidisciplinary DVT Unit Improves Clinical Outcomes and Post Thrombotic Syndrome. One-Year Experience in Our Hospital

High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster

RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1

Synergistic Pre-Clinical Activity of Targeted Inhibition of KDM1A and BET Proteins Against Human AML Blast Progenitor Cells

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Re-Presentation to Medical Care Due to Adverse Effects of Intravenous Immunoglobulin Therapy in Pediatric Immune Thrombocytopenia Patients

the Impact of Dedicated Emergency and Admission Units on Infection and Death Risks in Hematological Patients Presented toa Tertiary Care Center

Targeted Therapy for AML Expressing RUNX1 Mutation

Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients

Monitoring Voriconazole Pharmacogenomics and Plasma Concentrations in the Treatment and Prevention of Invasive Fungal Disease for Chinese Hematological Patients

Reperfusion Shutdown: Delayed Onset of Fibrinolysis Resistance after Resuscitation from Hemorrhagic Shock Is Associated with Increased Circulating Levels of Plasminogen Activator Inhibitor-1 and Postinjury Complications

Genome-Wide Abnormality Patterns of B-Lineage Acute Lymphoblastic Leukemia in Adults in Comparison with Pediatric Cases

The VIP (Very Immunocompromised Patient) Protocol: Improved Access To Care and Time To Antibiotics

Effector memory CD4 + T cells mediate graft-versus-leukemia without inducing graft-versus-host disease

Urgent Reversal of Warfarin Anticoagulation with Prothrombin Complex Concentrate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only